De | Medicines for Cancer | Buch | 978-0-443-13312-1 | sack.de

Buch, Englisch, Format (B × H): 151 mm x 229 mm, Gewicht: 1020 g

De

Medicines for Cancer

Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies
Erscheinungsjahr 2023
ISBN: 978-0-443-13312-1
Verlag: Elsevier Science & Technology

Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Buch, Englisch, Format (B × H): 151 mm x 229 mm, Gewicht: 1020 g

ISBN: 978-0-443-13312-1
Verlag: Elsevier Science & Technology


Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies covers most known anti-cancer therapeutics. Cancer is the second leading cause of death worldwide, with its various forms resulting in nearly one out of every six mortalities each year. This book describes all US FDA-approved drugs (up to 2021), such as small molecules, peptides, monoclonal antibodies, whole antibodies, gene therapy, antibody-drug conjugates, cell therapy, and immunotherapies, along with information on their generic and brand names, medical uses, details dosage, mechanisms of actions, pharmacokinetics and side effects. Chemical structures of small molecules, small peptides, antibody-drug conjugates are also provided.

This book is ideal for medicinal chemists, oncologists, and pharmacologists, but it will also be indispensable for professional researchers, whether they are working in the clinic or the pharmaceutical industry.
De Medicines for Cancer jetzt bestellen!

Zielgruppe


Researchers and postgraduate students in Medicinal Chemistry, Pharmacology, and other cancer-related fields.Oncologists and medical research professionals


Autoren/Hrsg.


Weitere Infos & Material


1. Nomenclature of drugs2. Chemotherapy3. Hormonal Therapy4. Targeted Therapy: Small Molecules 5. Targeted therapy: Monoclonal antibody6. Targeted Therapy: Antibody-drug conjugate (ADC)7. Immunotherapy


De, Surya K.
Dr De holds fifteen United States and international patents. Due to his abundant research contributions in the areas of cancer, metabolic diseases, organic and medicinal chemistry, and neuroscience, he has earned the distinction of Fellow of the Royal Society of Chemistry in 2010, and was subsequently awarded the status of Chartered Chemist in 2011. He is an elected Councilor in the American Chemical Society (San Diego section). He is editorial board member of Anticancer Agents in Medicinal Chemistry and Current Organic Synthesis.


Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.